SEQUESSOME TECHNOLOGY Trademark

Trademark Overview


On Tuesday, December 20, 2011, a trademark application was filed for SEQUESSOME TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the SEQUESSOME TECHNOLOGY trademark a serial number of 79115050. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, May 17, 2024. This trademark is owned by Pro Bono Bio Entrepreneur Limited. The SEQUESSOME TECHNOLOGY trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations and substances for the treatment of pain and inflammation; [ veterinary and sanitary preparations and substances for the treatment of pain and inflammation; chemical preparations for pharmaceutical purposes, namely, for the treatment of pain and inflammation; pharmaceuticals for the treatment of osteoarthritis, oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal diseases and central nervous system diseases; diagnostic preparations for medical and veterinary use; anti-inflammatory drugs; ] medicated creams, medicated dispersions, medicated lotions, medicated ointments, medicated gels [, medicated solutions, medicated sprays, medicated lacquers and pharmaceutical solutions which form a film on the skin for the treatment of pain or inflammation; chemical preparations for pharmaceutical or medical purposes, namely, the treatment of pain and inflammation; pharmaceuticals in the fields of osteoarthritis, oncology, card...

[ Medical devices in the nature of a carrier with nanostructures which cross through the skin allowing subcutaneous absorption for the treatment of pain; ] molecular filtering devices for medical use, namely, a liquid, gel or cream preparation as a drug delivery device which filters through or migrates into the skin and has a physical therapeutic effect; medical [ and veterinary ] devices, namely, a medical device in which vesicles act as a drug delivery device in the nature of non-pharmaceutical nanostructures that migrate through the skin and which contribute to the lubricating properties of synovial fluid [ ; medical instruments and devices for the administration of skin disease therapy and pain therapy and prophylaxis preparations and substances ]
sequessome technology

General Information


Serial Number79115050
Word MarkSEQUESSOME TECHNOLOGY
Filing DateTuesday, December 20, 2011
Status709 - CANCELLED - SECTION 71
Status DateFriday, May 17, 2024
Registration Number4427020
Registration DateTuesday, November 5, 2013
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of pain and inflammation; [ veterinary and sanitary preparations and substances for the treatment of pain and inflammation; chemical preparations for pharmaceutical purposes, namely, for the treatment of pain and inflammation; pharmaceuticals for the treatment of osteoarthritis, oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal diseases and central nervous system diseases; diagnostic preparations for medical and veterinary use; anti-inflammatory drugs; ] medicated creams, medicated dispersions, medicated lotions, medicated ointments, medicated gels [, medicated solutions, medicated sprays, medicated lacquers and pharmaceutical solutions which form a film on the skin for the treatment of pain or inflammation; chemical preparations for pharmaceutical or medical purposes, namely, the treatment of pain and inflammation; pharmaceuticals in the fields of osteoarthritis, oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal disease and central nervous system diseases, namely, vesicles which physically absorb and remove chemicals; pharmaceutical preparations, namely, topical and parenteral preparations in the form of vesicles; pharmaceutical preparations in the form of vesicles for medical and veterinary purposes; pharmaceutical preparations being chemical membranes and chemical aggregates for medical and veterinary purposes for the treatment of pain and inflammation; pharmaceutical preparations of arachidonic acids for the treatment of pain and inflammation; dispersions for pharmaceuticals for the treatment of pain and inflammation; medicated cosmetic and veterinary preparations, namely, dispersions and dry preparations of liposomal active substance carriers for the treatment of pain and inflammation; cosmeceutical preparations in the nature of medicated cosmetics; pharmaceutical preparations, namely, lipids for topical and parenteral use for the treatment of pain and inflammation; surfactants for medical use dispersed in the form of liquids, creams, gels, lotions, or liquid treatment sprays and lotions, being pharmaceutical preparations for the treatment of or prevention of cancer, infectious diseases, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders, the treatment of inflammation, asthma, atopic eczema, dishydrotic hand eczema, plaque-type psoriasis, seborrhoeic eczema, acne vulgaris, bronchospasm, atherothrombotic cardiovascular disorders, venous thrombotic disorders, pain, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, Alzheimer's disease, gout, macular degeneration, fungal disease and disorders related to fatty acid deficiencies ]
NOT AVAILABLE"TECHNOLOGY"
Goods and Services[ Medical devices in the nature of a carrier with nanostructures which cross through the skin allowing subcutaneous absorption for the treatment of pain; ] molecular filtering devices for medical use, namely, a liquid, gel or cream preparation as a drug delivery device which filters through or migrates into the skin and has a physical therapeutic effect; medical [ and veterinary ] devices, namely, a medical device in which vesicles act as a drug delivery device in the nature of non-pharmaceutical nanostructures that migrate through the skin and which contribute to the lubricating properties of synovial fluid [ ; medical instruments and devices for the administration of skin disease therapy and pain therapy and prophylaxis preparations and substances ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 17, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 17, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePro Bono Bio Entrepreneur Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBerkshire RG1 8LS
GB

Party NamePro Bono Bio Entrepreneur Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NamePro Bono Bio Entrepreneur Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Friday, August 10, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 2, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 3, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 3, 2012ASSIGNED TO EXAMINER
Tuesday, August 7, 2012APPLICATION FILING RECEIPT MAILED
Thursday, August 9, 2012NON-FINAL ACTION WRITTEN
Friday, March 8, 2013FINAL REFUSAL WRITTEN
Friday, August 10, 2012REFUSAL PROCESSED BY MPU
Friday, August 10, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, September 1, 2012REFUSAL PROCESSED BY IB
Monday, February 11, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 11, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 11, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 12, 2013ASSIGNED TO LIE
Thursday, February 14, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 14, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 8, 2013FINAL REFUSAL E-MAILED
Friday, March 8, 2013NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 31, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 20, 2013PUBLISHED FOR OPPOSITION
Monday, July 15, 2013TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, July 15, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 15, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 17, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 17, 2013ASSIGNED TO LIE
Wednesday, July 17, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 9, 2019NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, August 20, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, February 5, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, February 7, 2014FINAL DISPOSITION PROCESSED
Friday, February 7, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 28, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, March 14, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 14, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 5, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, January 7, 2022INTERNATIONAL REGISTRATION RENEWED
Tuesday, November 5, 2019TEAS SECTION 71 & 15 RECEIVED
Monday, December 9, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 3, 2020NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, January 7, 2020REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Tuesday, January 7, 2020NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Saturday, November 5, 2022COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Friday, May 17, 2024CANCELLED SECTION 71